Liraglutide is a type of medicine used to treat type 2 diabetes

Table of contents

Introduction
Marketing Strategy:
Other Polypeptide APIs Products

Introduction

: Liraglutide is a type of medicine used to treat type 2 diabetes. It is a glucagon-like peptide-1 (GLP-1) receptor agonist that works by stimulating insulin secretion and reducing glucagon levels in the body. In China, liraglutide has been approved for use since 2010 and is widely used in the treatment of diabetes.

Features and Benefits: Liraglutide has several features that make it an effective treatment for diabetes. Firstly, it can reduce blood glucose levels by up to 1.5% and also helps with weight loss. Secondly, it is administered once daily via subcutaneous injection, making it convenient for patients to take. Thirdly, it has a low risk of hypoglycemia, which is important for patient safety.

Marketing Strategy:

To market liraglutide effectively in China, it is important to focus on its unique features and benefits. One strategy could be to target healthcare professionals who treat patients with diabetes, such as endocrinologists and primary care physicians. This could involve educational programs and workshops that provide information on the benefits of liraglutide and how it can help their patients manage diabetes.

Another strategy could be to target patients directly through social media

China Chendu Shengnuo Biotechnology Co., Ltd which is mainly engaged in the research of polypeptide, polypeptide drug.
Our 0 defect has passed the FDA certification, and has become the first-class professional polypeptide drug and product development and large-scale production and export industry in China .
We have strong technical force, can carry out peptide product research and development, and meet the production and manufacturing capacity of international standards, and obtain the FDA certification.
Our products have been exported to Europe, America, Japan, Australia, Southeast Asia, the Middle East, South America, Africa and other countries and regions.